#Sinus Dilation Devices Market Research

[latestmarketresearchnews]

Sinus Dilation Devices Market 2030 Trending Key Companies, Growth and Regional Forecasts

The global market for sinus dilation devices was valued at approximately USD 2.74 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 9.6% from 2023 to 2030. Several factors are driving this growth, including a strong preference for minimally invasive procedures, favorable reimbursement policies, and an increase in awareness of the advantages of balloon sinuplasty compared to conventional treatments. Chronic sinusitis prevalence also contributes significantly to market demand. The development of advanced surgical techniques that replace traditional sinus procedures is boosting market dynamics, further enhancing growth.

One major contributor to these advancements is the introduction of cutting-edge technologies, such as surgical laser systems in sinus surgery, which allow for minimal tissue removal and result in fewer side effects. Additionally, these innovations reduce the procedure time, making it possible for many surgeries to be performed on an outpatient basis, which is highly convenient for patients and efficient for healthcare systems. An example of innovation in laser treatment includes the National Health Service's (NHS) introduction in 2022 of a new laser therapy for epilepsy patients. This treatment utilizes lasers to precisely target and address brain areas responsible for seizures, offering a new approach to epilepsy management that significantly improves patient quality of life. Such technological advances serve as a model for innovation in sinus surgery as well.

Gather more insights about the market drivers, restrains and growth of the Sinus Dilation Devices Market

The COVID-19 pandemic disrupted routine patient care, leading to a temporary halt in elective surgeries and regular clinic visits to free up healthcare resources and staff for intensive and inpatient care. This reallocation of resources impacted treatment options for patients with chronic rhinitis, who turned to teleconsultations and temporary care solutions for sinus-related issues.

In Canada, for instance, the pandemic led to a significant decline in the number of surgeries. During the first 31 months of the pandemic, there were approximately 937,000 fewer surgeries performed (a 14% reduction) compared to pre-pandemic levels. These figures are based on a comparison with 2019 surgery volumes, excluding factors such as population growth. The sharpest decline in surgeries occurred during the initial four months of the pandemic (March to June 2020) as both scheduled and non-urgent procedures were canceled or delayed in line with public health guidelines.

Application Segmentation Insights:

The adult patient segment dominated the sinus dilation device market in 2022, generating more than 65% of total revenue. This is primarily due to the high incidence of sinusitis in adults. According to the Centers for Disease Control and Prevention (CDC), over 28 million adults in the U.S. have been diagnosed with sinusitis, representing approximately 11.6% of the adult population. Sinusitis, a condition in which the air-filled spaces in the facial bones become inflamed, often results in symptoms such as nasal congestion, facial pain, and headaches. Proper management of sinusitis is crucial for alleviating these symptoms and enhancing overall health.

The pediatric segment is expected to exhibit the fastest CAGR, growing at 10.2% over the forecast period. This growth can be attributed to an increase in sinusitis cases among children. According to the National Center for Biotechnology Information (NCBI), around 6-13% of children in the U.S. developed chronic or acute rhinosinusitis by age three. Additionally, approximately 7.5% of upper respiratory infections, commonly known as colds, can lead to acute bacterial sinusitis (ABS) in children. ABS, however, is often underdiagnosed in young children, making it difficult to manage in primary care.

Several companies in the sinus dilation device market are focusing on developing products specifically designed for pediatric patients, further solidifying their market position. The NCBI provides updated guidelines to help healthcare providers better diagnose and treat bacterial sinus infections in children. These guidelines are designed to equip doctors with information on recognizing and managing bacterial sinus infections in young patients, which can improve outcomes and the quality of pediatric care.

Order a free sample PDF of the Sinus Dilation Devices Market Intelligence Study, published by Grand View Research.

[researchreportinsight]

Sinus Dilation Devices Market Outlook, Share, Opportunities and Forecast to 2030

The global market for sinus dilation devices was valued at approximately USD 2.74 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 9.6% from 2023 to 2030. Several factors are driving this growth, including a strong preference for minimally invasive procedures, favorable reimbursement policies, and an increase in awareness of the advantages of balloon sinuplasty compared to conventional treatments. Chronic sinusitis prevalence also contributes significantly to market demand. The development of advanced surgical techniques that replace traditional sinus procedures is boosting market dynamics, further enhancing growth.

One major contributor to these advancements is the introduction of cutting-edge technologies, such as surgical laser systems in sinus surgery, which allow for minimal tissue removal and result in fewer side effects. Additionally, these innovations reduce the procedure time, making it possible for many surgeries to be performed on an outpatient basis, which is highly convenient for patients and efficient for healthcare systems. An example of innovation in laser treatment includes the National Health Service's (NHS) introduction in 2022 of a new laser therapy for epilepsy patients. This treatment utilizes lasers to precisely target and address brain areas responsible for seizures, offering a new approach to epilepsy management that significantly improves patient quality of life. Such technological advances serve as a model for innovation in sinus surgery as well.

Gather more insights about the market drivers, restrains and growth of the Sinus Dilation Devices Market

The COVID-19 pandemic disrupted routine patient care, leading to a temporary halt in elective surgeries and regular clinic visits to free up healthcare resources and staff for intensive and inpatient care. This reallocation of resources impacted treatment options for patients with chronic rhinitis, who turned to teleconsultations and temporary care solutions for sinus-related issues.

In Canada, for instance, the pandemic led to a significant decline in the number of surgeries. During the first 31 months of the pandemic, there were approximately 937,000 fewer surgeries performed (a 14% reduction) compared to pre-pandemic levels. These figures are based on a comparison with 2019 surgery volumes, excluding factors such as population growth. The sharpest decline in surgeries occurred during the initial four months of the pandemic (March to June 2020) as both scheduled and non-urgent procedures were canceled or delayed in line with public health guidelines.

Application Segmentation Insights:

The adult patient segment dominated the sinus dilation device market in 2022, generating more than 65% of total revenue. This is primarily due to the high incidence of sinusitis in adults. According to the Centers for Disease Control and Prevention (CDC), over 28 million adults in the U.S. have been diagnosed with sinusitis, representing approximately 11.6% of the adult population. Sinusitis, a condition in which the air-filled spaces in the facial bones become inflamed, often results in symptoms such as nasal congestion, facial pain, and headaches. Proper management of sinusitis is crucial for alleviating these symptoms and enhancing overall health.

The pediatric segment is expected to exhibit the fastest CAGR, growing at 10.2% over the forecast period. This growth can be attributed to an increase in sinusitis cases among children. According to the National Center for Biotechnology Information (NCBI), around 6-13% of children in the U.S. developed chronic or acute rhinosinusitis by age three. Additionally, approximately 7.5% of upper respiratory infections, commonly known as colds, can lead to acute bacterial sinusitis (ABS) in children. ABS, however, is often underdiagnosed in young children, making it difficult to manage in primary care.

Several companies in the sinus dilation device market are focusing on developing products specifically designed for pediatric patients, further solidifying their market position. The NCBI provides updated guidelines to help healthcare providers better diagnose and treat bacterial sinus infections in children. These guidelines are designed to equip doctors with information on recognizing and managing bacterial sinus infections in young patients, which can improve outcomes and the quality of pediatric care.

Order a free sample PDF of the Sinus Dilation Devices Market Intelligence Study, published by Grand View Research.

[global-research-report]

Sinus Dilation Devices Market Analysis: Applications, Technologies & Growth  2023 - 2030

The global sinus dilation devices market size is estimated to reach USD 5.69 billion by 2030, registering a CAGR of 9.6%, according to a new report by Grand View Research, Inc. Changes in lifestyle, increasing cases of obesity, and a resultant rise in the incidence of sinus-related conditions are the major factors contributing to the market growth. The introduction of technologically advanced devices is also one of the key factors boosting market growth. Major market players are focusing on R&D activities to introduce minimally invasive procedures creating a positive impact on the adoption of MIS procedures.

Some of the inventions in the market related to endoscopic approaches include a nasal endoscope, rhinoscopes, and balloon sinus dilation devices. An increase in medical reimbursements across major markets is likely to fuel the market growth. Rising adoption of health insurance and growing per capita expenditure coupled in developed as well as developing countries is predicted to augment the market growth.

Gather more insights about the market drivers, restrains and growth of the Sinus Dilation Devices Market

In November 2017, Entellus Medical, Inc. announced that Anthem, Inc., an American health insurance company, provided insurance coverage for Balloon Sinus Dilation (BSD) used in the treatment of recurrent acute sinusitis and chronic sinusitis. Anthem, Inc. is a member of the Blue Cross Blue Shield Association, the second-largest health benefits plan provider that covers around 40 million people in the U.S. Other major health insurance companies providing coverage for standalone BSD are Medicare, Aetna, Cigna, TRICARE, Humana, Health Net, Kaiser, and United Healthcare.

Browse through Grand View Research's Medical Devices Industry Research Reports.

The global nasal packing devices market sizewas valued at USD 205.2 million in 2024 and is projected to grow at a CAGR of 5.1% from 2025 to 2030.

The global ligation devices market sizewas estimated at USD 1.2 billion in 2024 and is expected to grow at a CAGR of 7.0% from 2025 to 2030. 

Sinus Dilation Devices Market Segmentation

Grand View Research has segmented the global sinus dilation device market on the basis of product, Type, procedure, application, end-use, and region:

Sinus Dilation Devices Product Outlook (Revenue in USD Million, 2018 - 2030)

Ballon Sinus Dilation Devices

Endoscopes 

Sinus Stents/Implants 

Functional Endoscopic Sinus Surgery (FESS) Instruments Set

Others

Sinus Dilation Devices Type Outlook (Revenue in USD Million, 2018 - 2030)

Sinuscopes

Rhinoscopes

Sinus Dilation Devices Procedure Outlook (Revenue in USD Million, 2018 - 2030)

Standalone

Hybrid

Sinus Dilation Devices Application Outlook (Revenue in USD Million, 2018 - 2030)

Adult

Pediatric

Sinus Dilation Devices End-use Outlook (Revenue in USD Million, 2018 - 2030)

Hospitals 

Ambulatory Surgical Centers 

ENT Clinics/In Office

Sinus Dilation Devices Regional Outlook (Revenue in USD Million, 2018 - 2030)

North America

US

Canada

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

Thailand

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East and Africa

South Africa

Saudi Arabia

UAE

Kuwait

Key Companies profiled:

Medtronic

Smith+Nephew

Stryker

Intersect ENT, Inc

Olympus Corporation

SinuSys Corporation

Johnson & Johnson Services, Inc.

TE Connectivity

InnAccel Technologies Pvt Ltd

Order a free sample PDF of the Sinus Dilation Devices Market Intelligence Study, published by Grand View Research.

[marketanalysisdata]

Sinus Dilation Devices Industry Analysis, Research, Review, Applications and Forecast to 2030

The global sinus dilation devices market was valued at USD 2.74 billion in 2022, with an anticipated growth rate of 9.6% CAGR from 2023 to 2030. This growth is largely driven by an increasing preference for minimally invasive procedures, favorable reimbursement policies, greater awareness of the benefits of balloon sinuplasty over traditional methods, and the high prevalence of chronic sinusitis. The development of advanced surgical techniques has improved patient outcomes and accelerated the replacement of traditional methods, boosting the demand for sinus dilation devices.

One notable area of technological advancement in sinus surgery is the use of surgical lasers. These advancements help ensure minimal ablation, which results in fewer side effects and enables procedures to be completed quickly, often in outpatient settings. For instance, the UK's National Health Service (NHS) introduced a novel laser treatment for epilepsy patients in 2022, highlighting the importance of laser technology in providing innovative, effective treatment options and improving patients' quality of life.

The COVID-19 pandemic significantly disrupted routine healthcare services, including treatments for chronic rhinitis and other sinus-related issues. Many healthcare facilities postponed elective surgeries and routine visits to prioritize the availability of intensive care and inpatient beds for COVID-19 patients. This shift in healthcare priorities led patients with sinus issues to seek alternative care methods, including teleconsultations and temporary remedies.

Gather more insights about the market drivers, restrains and growth of the Sinus Dilation Devices Market

Regional Insights:

North America Sinus Dilation Devices Market Trends

North America led the sinus dilation devices market in 2022, contributing over 40% of global revenue. This dominance is due to the region’s highly developed healthcare infrastructure and the availability of advanced products from major companies in the sector. The U.S. healthcare system, for instance, is a mix of public and private services. Government programs like Medicare and Medicaid provide coverage for specific groups, while most individuals obtain private health insurance, often through employers. The Affordable Care Act has contributed to a decline in the uninsured population by expanding coverage options. Public and private insurers in the U.S. determine coverage and costs under federal and state regulations, creating a comprehensive system with both government-funded and private insurance options.

Asia Pacific Sinus Dilation Devices Market Trends

The Asia Pacific region is expected to see the fastest market growth, with a projected CAGR of 10.4% from 2023 to 2030. Key factors driving this growth include rising disposable incomes and increased awareness of sinus treatment options. According to a report by the Organization for Economic Co-operation and Development (OECD), emerging Asian countries such as China, India, and the ASEAN-10 nations showed economic resilience during the COVID-19 pandemic and global economic downturn. Their economies are projected to grow by 5.3% in 2023 and 5.4% in 2024, with ASEAN economies expected to grow by around 4.6% in 2023 and 4.8% in 2024, highlighting their ability to rebound and sustain economic progress.

Browse through Grand View Research's Category Medical Devices Industry Research Reports.

The global pediatric clinical trials market size was estimated at USD 19.9 billion in 2024 and is projected to grow at a CAGR of 5.25% from 2025 to 2030.

The global non-alcoholic steatohepatitis clinical trials market size was estimated at USD 2.92 billion in 2024 and is projected to grow at a CAGR of 6.26% from 2025 to 2030.

Key Companies & Market Share Insights:

Major players in the sinus dilation devices market are pursuing various growth strategies, including mergers and acquisitions, technological innovations, promotional activities, and device enhancements. For example, Intersect ENT, Inc., a prominent provider of medical technology for ear, nose, and throat care, introduced a new product in the U.S. market that combines the Straight Delivery System (SDS) with the PROPEL Mini Sinus Implant. This combined system received approval from the U.S. Food and Drug Administration (FDA) in July 2020, making it available for use in clinical settings. By developing and launching FDA-approved devices, Intersect ENT and other companies can expand their offerings and cater to the increasing demand for advanced sinus dilation solutions.

In summary, the sinus dilation devices market is experiencing growth driven by the demand for minimally invasive solutions, supportive reimbursement policies, and innovations in surgical technology. North America holds a dominant position due to its established healthcare infrastructure, while Asia Pacific is poised for rapid expansion as awareness and economic growth support greater healthcare access and innovation.

Key Sinus Dilation Devices Companies:

Medtronic

Smith+Nephew

Stryker

Intersect ENT, Inc

Olympus Corporation

SinuSys Corporation

Johnson & Johnson Services, Inc.

TE Connectivity

InnAccel Technologies Pvt Ltd

Order a free sample PDF of the Sinus Dilation Devices Market Intelligence Study, published by Grand View Research.

[marketstudyreport]

Sinus Dilation Devices Market 2030 Outlook, Regions, Size Estimation and Upcoming Trend

The global sinus dilation devices market was valued at USD 2.74 billion in 2022, with an anticipated growth rate of 9.6% CAGR from 2023 to 2030. This growth is largely driven by an increasing preference for minimally invasive procedures, favorable reimbursement policies, greater awareness of the benefits of balloon sinuplasty over traditional methods, and the high prevalence of chronic sinusitis. The development of advanced surgical techniques has improved patient outcomes and accelerated the replacement of traditional methods, boosting the demand for sinus dilation devices.

One notable area of technological advancement in sinus surgery is the use of surgical lasers. These advancements help ensure minimal ablation, which results in fewer side effects and enables procedures to be completed quickly, often in outpatient settings. For instance, the UK's National Health Service (NHS) introduced a novel laser treatment for epilepsy patients in 2022, highlighting the importance of laser technology in providing innovative, effective treatment options and improving patients' quality of life.

The COVID-19 pandemic significantly disrupted routine healthcare services, including treatments for chronic rhinitis and other sinus-related issues. Many healthcare facilities postponed elective surgeries and routine visits to prioritize the availability of intensive care and inpatient beds for COVID-19 patients. This shift in healthcare priorities led patients with sinus issues to seek alternative care methods, including teleconsultations and temporary remedies.

Gather more insights about the market drivers, restrains and growth of the Sinus Dilation Devices Market

Regional Insights:

North America Sinus Dilation Devices Market Trends

North America led the sinus dilation devices market in 2022, contributing over 40% of global revenue. This dominance is due to the region’s highly developed healthcare infrastructure and the availability of advanced products from major companies in the sector. The U.S. healthcare system, for instance, is a mix of public and private services. Government programs like Medicare and Medicaid provide coverage for specific groups, while most individuals obtain private health insurance, often through employers. The Affordable Care Act has contributed to a decline in the uninsured population by expanding coverage options. Public and private insurers in the U.S. determine coverage and costs under federal and state regulations, creating a comprehensive system with both government-funded and private insurance options.

Asia Pacific Sinus Dilation Devices Market Trends

The Asia Pacific region is expected to see the fastest market growth, with a projected CAGR of 10.4% from 2023 to 2030. Key factors driving this growth include rising disposable incomes and increased awareness of sinus treatment options. According to a report by the Organization for Economic Co-operation and Development (OECD), emerging Asian countries such as China, India, and the ASEAN-10 nations showed economic resilience during the COVID-19 pandemic and global economic downturn. Their economies are projected to grow by 5.3% in 2023 and 5.4% in 2024, with ASEAN economies expected to grow by around 4.6% in 2023 and 4.8% in 2024, highlighting their ability to rebound and sustain economic progress.

Browse through Grand View Research's Category Medical Devices Industry Research Reports.

The global pediatric clinical trials market size was estimated at USD 19.9 billion in 2024 and is projected to grow at a CAGR of 5.25% from 2025 to 2030.

The global non-alcoholic steatohepatitis clinical trials market size was estimated at USD 2.92 billion in 2024 and is projected to grow at a CAGR of 6.26% from 2025 to 2030.

Key Companies & Market Share Insights:

Major players in the sinus dilation devices market are pursuing various growth strategies, including mergers and acquisitions, technological innovations, promotional activities, and device enhancements. For example, Intersect ENT, Inc., a prominent provider of medical technology for ear, nose, and throat care, introduced a new product in the U.S. market that combines the Straight Delivery System (SDS) with the PROPEL Mini Sinus Implant. This combined system received approval from the U.S. Food and Drug Administration (FDA) in July 2020, making it available for use in clinical settings. By developing and launching FDA-approved devices, Intersect ENT and other companies can expand their offerings and cater to the increasing demand for advanced sinus dilation solutions.

In summary, the sinus dilation devices market is experiencing growth driven by the demand for minimally invasive solutions, supportive reimbursement policies, and innovations in surgical technology. North America holds a dominant position due to its established healthcare infrastructure, while Asia Pacific is poised for rapid expansion as awareness and economic growth support greater healthcare access and innovation.

Key Sinus Dilation Devices Companies:

Medtronic

Smith+Nephew

Stryker

Intersect ENT, Inc

Olympus Corporation

SinuSys Corporation

Johnson & Johnson Services, Inc.

TE Connectivity

InnAccel Technologies Pvt Ltd

Order a free sample PDF of the Sinus Dilation Devices Market Intelligence Study, published by Grand View Research.

[health-views-updates]

Functional Endoscopic Sinus Surgery Market 2024 Size, Share, Global Analysis and Future Trends by 2032

The global Functional Endoscopic Sinus Surgery Market Revenue is set to experience significant growth due to advancements in medical technology and rising awareness about effective sinus treatment options. According to the latest market report by SNS Insider, the FESS market is being propelled by an increase in chronic sinusitis cases worldwide, a higher preference for minimally invasive surgical techniques, and the integration of high-definition imaging and navigation technologies in sinus surgeries. These developments promise to improve patient outcomes, reduce recovery time, and enhance surgical precision.

Functional Endoscopic Sinus Surgery, commonly known as FESS, has gained prominence as a highly effective treatment for chronic sinusitis and related conditions that are resistant to medication. By allowing surgeons to access and treat sinus regions with minimal incisions, FESS has become a preferred option for patients and healthcare providers alike. The report by SNS Insider highlights that the increasing prevalence of chronic rhinosinusitis, the growing geriatric population, and the rise in allergies worldwide are fueling the demand for FESS procedures. Additionally, advancements in healthcare infrastructure and supportive government initiatives in various regions further bolster market growth.

Technological advancements, including the use of image-guided navigation systems, improved endoscopic tools, and sophisticated visualization techniques, have greatly enhanced the efficiency and safety of FESS. These innovations allow for greater precision in surgery, minimizing complications and improving post-operative recovery times. The report indicates that as healthcare providers continue to adopt these advancements, the market is expected to witness significant growth in the coming years, particularly in developed economies where healthcare infrastructure is advanced and readily adaptable to new technologies.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/4457

The FESS market also benefits from a growing awareness among patients regarding the availability and effectiveness of endoscopic sinus surgeries. Healthcare providers are focusing on educating patients about the benefits of FESS compared to traditional sinus surgery, as it offers a less invasive solution with faster recovery periods and fewer risks. Coupled with this increased awareness, the expansion of insurance coverage and favorable reimbursement policies in many regions further encourage patients to opt for FESS. Consequently, the FESS market is well-positioned to cater to a growing patient pool looking for advanced sinus care solutions.

With rising demand, key players in the FESS market are investing in research and development to introduce novel products and devices. This includes advancements in micro-instruments, balloon sinus dilation, and robotic-assisted surgeries, all designed to enhance surgical accuracy and patient outcomes. The report indicates that these innovations are not only enhancing the capabilities of healthcare providers but also creating a competitive environment where manufacturers strive to deliver cutting-edge products. This competition is expected to drive further innovation and investment, ultimately benefiting both patients and providers.

Regional Insights and Future Market Prospects

The report provides a detailed analysis of the FESS market across various regions, noting that North America currently holds a significant share due to its advanced healthcare infrastructure, high disposable incomes, and well-established healthcare policies. Europe is also a prominent market for FESS, supported by robust healthcare systems and an increasing demand for minimally invasive surgical options. In contrast, emerging economies in Asia-Pacific are experiencing rapid growth in the FESS market, driven by improving healthcare facilities, growing medical tourism, and a higher focus on advanced treatment options.

Looking ahead, the FESS market is expected to maintain a steady growth trajectory, supported by continuous technological advancements and an increasing focus on patient-centered care. As more people become aware of the advantages of FESS, and as technology makes these procedures safer and more effective, the market will continue to expand. Moreover, the increasing investments in healthcare infrastructure, especially in developing countries, create new opportunities for growth.

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Akash Anand – Head of Business Development & Strategy info@snsinsider.com Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

[stevenwilliam12]

CAR-T Therapy Market Set for Substantial Growth by 2034: Size, Trends, and Future Opportunities

In the realm of cancer treatment, Chimeric Antigen Receptor T-cell (CAR-T) therapy has emerged as a groundbreaking innovation, particularly transforming outcomes for hematologic cancers like Non-Hodgkin’s Lymphoma (NHL) and acute lymphoblastic leukemia (ALL). Offering new hope for patients resistant to conventional treatments, the CAR-T therapy market is poised for significant expansion driven by scientific advancements and a widening patient base.

Market Dynamics and Growth Prospects

The CAR-T therapy market has witnessed robust growth, buoyed by rising adoption rates and an expanding repertoire of therapeutic applications. Pioneered by landmark approvals such as Kymriah by Novartis and Yescarta by Gilead Sciences, these therapies have paved the way for broader acceptance and utilization across hematologic malignancies. Looking ahead, the market anticipates further acceleration with promising developments in CAR-T treatments tailored for solid tumors.

Key Players Shaping the Landscape

Leading pharmaceutical and biotech entities have taken center stage in the CAR-T arena, driving innovation and competition. Notable players include Gilead Sciences, renowned for Yescarta, Novartis with its pioneering Kymriah, and Bristol-Myers Squibb among others. These industry giants are committed to refining therapeutic efficacy, reducing adverse effects, and expanding the scope of CAR-T therapies to encompass a wider spectrum of cancers.

Expanding Target Population and Market Reach

Initially focused on hematologic cancers, CAR-T therapies are increasingly poised to benefit a growing demographic. Factors such as rising cancer incidences, aging populations, and the extension of CAR-T therapy into earlier treatment lines are set to amplify market demand. Moreover, ongoing efforts to broaden indications to include solid tumors promise to further diversify and enlarge the eligible patient pool.

Competitive Dynamics and Future Outlook

The CAR-T landscape is marked by intense competition, where established firms and emerging biotech enterprises vie for prominence. Companies like Autolus Therapeutics and Allogene Therapeutics are spearheading innovative CAR-T developments aimed at refining therapeutic outcomes and optimizing manufacturing processes. This competitive milieu is projected to foster continual advancements, ensuring CAR-T therapies remain at the forefront of cancer care innovation.

Market Drivers and Forecasts

Driving the expansion of the CAR-T market are advancements in manufacturing technologies, enhanced patient response rates, and a robust pipeline targeting various cancer types. Projections indicate sustained growth propelled by expanded therapeutic indications and advancements in early-stage treatment protocols. Despite challenges related to cost and logistical complexities, ongoing research collaborations and manufacturing efficiencies are anticipated to mitigate these barriers.

Conclusion

As we look towards 2034, the CAR-T therapy market stands poised for transformative growth. With evolving research insights, broadening therapeutic applications, and a global footprint, CAR-T therapies are set to redefine cancer treatment paradigms. The journey ahead promises new opportunities for innovation and patient-centric care, solidifying CAR-T therapy’s pivotal role in shaping the future of oncology.

Latest Reports Offered By DeveInsight:

Stenosis Medical Devices Market | Wide Neck Bifurcation Intracranial Aneurysms Market | B-cell Non-hodgkin Lymphoma Market | Bulimia Nervosa Market | Dysautonomia Market | Hemorrhoids Market | Holter Monitor Market | Sacral Nerve Stimulator Market | Sinus Dilation Devices Market | Tendinitis Market | Vulvodynia Market | Anti Hypertension Market | Asthma Market | Castration-resistant Prostate Cancer Market | Extracorporeal Membrane Oxygenation Devices/ Extracorporeal Circulation System Market | Gastro-oesophageal Reflux Disease Market | Gonorrhea Market | Hernia Repair Devices Market | Idiopathic Thrombocytopenic Purpura Market | Monkeypox Market | Myelodysplastic Syndrome Market | Retinoblastoma Market | Sinusitis Market | Systemic Sclerosis Market | Atherectomy Devices Market | Hypercalcemia Market | Primary Progessive Multiple Sclerosis Market

[industrynewsupdates]

Sinus Dilation Devices Market Key Companies, Growth and Forecast Report, 2030

The global sinus dilation devices market size is estimated to reach USD 5.69 billion by 2030, registering a CAGR of 9.6%, according to a new report by Grand View Research, Inc. Changes in lifestyle, increasing cases of obesity, and a resultant rise in the incidence of sinus-related conditions are the major factors contributing to the market growth. The introduction of technologically advanced devices is also one of the key factors boosting market growth. Major market players are focusing on R&D activities to introduce minimally invasive procedures creating a positive impact on the adoption of MIS procedures.

Some of the inventions in the market related to endoscopic approaches include a nasal endoscope, rhinoscopes, and balloon sinus dilation devices. An increase in medical reimbursements across major markets is likely to fuel the market growth. Rising adoption of health insurance and growing per capita expenditure coupled in developed as well as developing countries is predicted to augment the market growth.

In November 2017, Entellus Medical, Inc. announced that Anthem, Inc., an American health insurance company, provided insurance coverage for Balloon Sinus Dilation (BSD) used in the treatment of recurrent acute sinusitis and chronic sinusitis. Anthem, Inc. is a member of the Blue Cross Blue Shield Association, the second-largest health benefits plan provider that covers around 40 million people in the U.S. Other major health insurance companies providing coverage for standalone BSD are Medicare, Aetna, Cigna, TRICARE, Humana, Health Net, Kaiser, and United Healthcare.

Gather more insights about the market drivers, restrains and growth of the Sinus Dilation Devices Market

Detailed Segmentation:

Application Insights

The adult patient segment accounted for the highest revenue share of more than 65% in 2022, owing to the high prevalence of sinusitis in adults. According to the Centers for Disease Control and Prevention (CDC), over 28 million adults in the U.S. have been diagnosed with sinusitis. This condition affects about 11.6% of all adults in the country. Sinusitis is a common health issue where the sinuses, which are air-filled spaces in the face, become inflamed and can cause symptoms such as nasal congestion, facial pain, and headaches. It's essential to manage sinusitis properly to alleviate discomfort and improve overall health.

Regional Insights

North America dominates the sinus dilation devices market in terms of revenue, accounting for a share of over 40% in 2022. The dominance can be attributed to highly regulated and developed healthcare infrastructure. Moreover, the availability of advanced products due to the presence of major market players is boosting market growth.

According to The Commonwealth Fund, the healthcare system in the U.S. is a combination of public and private organizations. The federal government funds programs such as Medicare for older adults and some people with disabilities, as well as programs for veterans and low-income individuals such as Medicaid and the Children's Health Insurance Program. States also manage some local coverage and safety net programs. Many people have private health insurance provided by their employers, the most common type of coverage. The number of people without insurance has decreased over the years due to the Affordable Care Act. Both public and private insurers decide what services they will cover and how much individuals have to pay, following certain rules and regulations set by the federal and state governments. In simple terms, the US healthcare system involves a mix of government-funded and private insurance options that provide coverage to different groups of people.

Product Insights

The Balloon Sinus Dilation (BSD) devices segment captured the largest revenue share of more than 45% in 2022. BSDs are safe, small, flexible, and effective in improving symptoms of sinusitis. As the sinus dilation procedure does not involve tissue ablation, it results in quick turnaround time and patient comfort. However, BSD procedures are temporary, and patients may have to undergo repeat procedures. Balloon sinuplasty is used to treat chronic rhinosinusitis (CRS), a long-term inflammation of the sinuses.

Type Insights

The sinuscopes segment captured the largest revenue share of around 60% in 2022 and is expected to grow at a CAGR of 9.5% over the forecast period. Growing preference for minimally invasive procedures and advances in sinuscope technology are expected to drive segment growth. For instance, in 2017, Stryker launched the Stryker VR Sinus Surgery Simulator, which helps surgeons train for sinus surgeries. The simulator uses a realistic 3D model of the sinuses to create a virtual environment for surgeons to practice their skills. The simulator also provides feedback on the surgeon's performance, which can help them to improve their skills.

Procedure Insights

The standalone procedure segment captured the highest revenue share of over 65% in 2022. Balloon sinus ostial dilation is performed as a standalone procedure. Standalone balloon dilation is as effective as functional endoscopic sinus surgery for treating chronic rhinosinusitis. In addition, the rising preference for minimally invasive surgical procedures due to increased adoption of health insurance is anticipated to fuel segment growth.

According to census.gov, between 2020 and 2021, there was a slight decline in the number of uninsured people in the U.S. In 2020, 8.6% of the population, equivalent to 28.3 million individuals, lacked health insurance throughout the year. This number decreased to 8.3% in 2021, with approximately 27.2 million uninsured people. Private health insurance coverage remained more common than public coverage in 2021. About 66.0% of individuals had private health insurance, while 35.7% had public coverage. Employer-based insurance was the most prevalent type among those with private health insurance, covering 54.3% of the population. On the other hand, Medicaid was the most common form of public health insurance, providing coverage to 18.9% of the population.

End-use Insights

The hospitals segment accounted for the largest revenue share of around 50% in 2022 and is expected to witness considerable growth during the forecast period owing to the high volume of surgical procedures performed in hospitals. The increasing prevalence of chronic sinusitis coupled with favorable reimbursement criteria is anticipated to boost the segment growth. The availability of technologically advanced infrastructure and medical equipment along with the ability to perform complex sinus surgeries are projected to boost segment growth.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global breast shells market size was valued at USD 71.0 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2030. 

• The global biosimilar contract manufacturing market was valued at USD 8.59 billion in 2023 and is expected to grow at a CAGR of 15.9% during the forecast period.

Key Companies & Market Share Insights

Key players in the market are focusing on adopting growth strategies, such as mergers and acquisitions, developing existing devices, promotional events, and technological advancements. For instance, Intersect ENT, Inc., one of the leading medical technology companies for ear, nose, and throat care, introduced a new product in the U.S. called the Straight Delivery System (SDS) along with the PROPEL Mini Sinus Implant (a medical device). The U.S. Food and Drug Administration has approved this combined packaging, making it available for use. The Straight Delivery System was previously approved in July 2020. In simple terms, Intersect ENT has launched a new product in the U.S. that includes a medical device called the SDS and the PROPEL Mini Sinus Implant, which the FDA has approved for use.

Key Sinus Dilation Devices Companies:

• Medtronic

• Smith+Nephew

• Stryker

• Intersect ENT, Inc

• Olympus Corporation

• SinuSys Corporation

• Johnson & Johnson Services, Inc.

• TE Connectivity

• InnAccel Technologies Pvt Ltd

Sinus Dilation Devices Market Segmentation

Grand View Research has segmented the global sinus dilation device market on the basis of product, Type, procedure, application, end-use, and region:

Sinus Dilation Devices Product Outlook (Revenue in USD Million, 2018 - 2030)

• Ballon Sinus Dilation Devices

• Endoscopes 

• Sinus Stents/Implants 

• Functional Endoscopic Sinus Surgery (FESS) Instruments Set

• Others

Sinus Dilation Devices Type Outlook (Revenue in USD Million, 2018 - 2030)

• Sinuscopes

• Rhinoscopes

Sinus Dilation Devices Procedure Outlook (Revenue in USD Million, 2018 - 2030)

• Standalone

• Hybrid

Sinus Dilation Devices Application Outlook (Revenue in USD Million, 2018 - 2030)

• Adult

• Pediatric

Sinus Dilation Devices End-use Outlook (Revenue in USD Million, 2018 - 2030)

• Hospitals 

• Ambulatory Surgical Centers 

• ENT Clinics/In Office

Sinus Dilation Devices Regional Outlook (Revenue in USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o UK

o Germany

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

• Asia Pacific

o Japan

o China

o India

o Australia

o Thailand

o South Korea

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East and Africa

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Order a free sample PDF of the Sinus Dilation Devices Market Intelligence Study, published by Grand View Research.

[tamanna31]

Sinus Dilation Devices Market Size, Share, Growth, Analysis Forecast to 2030

Sinus Dilation Devices Industry Overview

The global sinus dilation devices market size was valued at USD 2.74 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 9.6% from 2023 to 2030.

The high preference for minimally invasive procedures, favorable reimbursement scenarios, rising awareness about the advantages of balloon sinuplasty over other conventional techniques, and the prevalence of chronic sinusitis are the major factors fostering the market growth. Developing advanced surgery techniques helps increase the market dynamics by replacing traditional procedures.

Gather more insights about the market drivers, restrains and growth of the Sinus Dilation Devices Market

Technological advancements, such as surgical laser technologies, in sinus surgery ensure minimal ablation and have fewer side effects. Decreased turnaround time enables these procedures to be performed in outpatient departments. For instance, in 2022, the National Health Service (NHS) introduced an innovative laser treatment for patients with epilepsy. This pioneering therapy utilizes lasers to target and treat areas of the brain that cause seizures, providing a new and advanced approach to managing epilepsy and improving patients' quality of life.

The COVID-19 pandemic led to interruptions in routine patient care. Many healthcare organizations have canceled routine clinic visits and elective surgeries to increase and maintain the availability of intensive care and inpatient care beds and have reorganized medical and nursing staff. This has particularly interrupted care for patients with chronic rhinitis. The patients opted for teleconsultations and temporary options for sinus-related problems.

For instance, in Canada, there was a significant decline in the number of surgeries during the first 31 months of the pandemic, amounting to approximately 937,000 fewer surgeries (14%) compared to the pre-pandemic period. These figures were determined by comparing the surgeries performed since March 2020 to a baseline of 2019 without considering population growth or other factors. The most substantial drop in surgeries occurred in the initial four months of the pandemic (March to June 2020), when many scheduled and non-urgent procedures were postponed or canceled across the country to align with public health guidelines.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global embolic protection devices market size was valued at USD 612.9 million in 2023 and is projected to grow at a CAGR of 8.7% from 2024 to 2030.

• The global bone densitometers market size was valued at USD 241.2 million in 2023 and is projected to grow at a CAGR of 4.5% from 2024 to 2030.

Global Sinus Dilation Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global sinus dilation devices market based on product, type, procedure, application, end use, and region.

Product Outlook (Revenue in USD Million, 2018 - 2030)

Ballon Sinus Dilation Devices

Endoscopes 

Sinus Stents/Implants 

Functional Endoscopic Sinus Surgery (FESS) Instruments Set

Others

Type Outlook (Revenue in USD Million, 2018 - 2030)

Sinuscopes

Rhinoscopes

Procedure Outlook (Revenue in USD Million, 2018 - 2030)

Standalone

Hybrid

Application Outlook (Revenue in USD Million, 2018 - 2030)

Adult

Pediatric

End-use Outlook (Revenue in USD Million, 2018 - 2030)

Hospitals 

Ambulatory Surgical Centers 

ENT Clinics/In Office

Regional Outlook (Revenue in USD Million, 2018 - 2030)

North America

US

Canada

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

Thailand

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East and Africa

South Africa

Saudi Arabia

UAE

Kuwait

Key Companies & Market Share Insights

Key players in the market are focusing on adopting growth strategies, such as mergers and acquisitions, developing existing devices, promotional events, and technological advancements. For instance, Intersect ENT, Inc., one of the leading medical technology companies for ear, nose, and throat care, introduced a new product in the U.S. called the Straight Delivery System (SDS) along with the PROPEL Mini Sinus Implant (a medical device). The U.S. Food and Drug Administration has approved this combined packaging, making it available for use. The Straight Delivery System was previously approved in July 2020. In simple terms, Intersect ENT has launched a new product in the U.S. that includes a medical device called the SDS and the PROPEL Mini Sinus Implant, which the FDA has approved for use:

Medtronic

Smith+Nephew

Stryker

Intersect ENT, Inc

Olympus Corporation

SinuSys Corporation

Johnson & Johnson Services, Inc.

TE Connectivity

InnAccel Technologies Pvt Ltd

Order a free sample PDF of the Sinus Dilation Devices Market Intelligence Study, published by Grand View Research.

[healthcaremarketresearchsblog]

Sinus Dilation Market To Register Unwavering Growth By 2031 - The Insight Partners

The Insight Partners recently announced the release of the market research titled Sinus Dilation Market Outlook to 2027 | Share, Size, and Growth. The report is a stop solution for companies operating in the Sinus Dilation market. The report involves details on key segments, market players, precise market revenue statistics, and a roadmap that assists companies in advancing their offerings and preparing for the upcoming decade. Listing out the opportunities in the market, this report intends to prepare businesses for the market dynamics in an estimated period.

Is Investing in the Market Research Worth It?

Some businesses are just lucky to manage their performance without opting for market research, but these incidences are rare. Having information on longer sample sizes helps companies to eliminate bias and assumptions. As a result, entrepreneurs can make better decisions from the outset. Sinus Dilation Market report allows business to reduce their risks by offering a closer picture of consumer behavior, competition landscape, leading tactics, and risk management.

A trusted market researcher can guide you to not only avoid pitfalls but also help you devise production, marketing, and distribution tactics. With the right research methodologies, The Insight Partners is helping brands unlock revenue opportunities in the Sinus Dilation market.

If your business falls under any of these categories – Manufacturer, Supplier, Retailer, or Distributor, this syndicated Sinus Dilation market research has all that you need.

What are Key Offerings Under this Sinus Dilation Market Research?

Global Sinus Dilation market summary, current and future Sinus Dilation market size

Market Competition in Terms of Key Market Players, their Revenue, and their Share

Economic Impact on the Industry

Production, Revenue (value), Price Trend

Cost Investigation and Consumer Insights

Industrial Chain, Raw Material Sourcing Strategy, and Downstream Buyers

Production, Revenue (Value) by Geographical Segmentation

Marketing Strategy Comprehension, Distributors and Traders

Global Sinus Dilation Market Forecast

Study on Market Research Factors

Who are the Major Market Players in the Sinus Dilation Market?

Sinus Dilation market is all set to accommodate more companies and is foreseen to intensify market competition in coming years. Companies focus on consistent new launches and regional expansion can be outlined as dominant tactics. Sinus Dilation market giants have widespread reach which has favored them with a wide consumer base and subsequently increased their Sinus Dilation market share.

Report Attributes

Details

Segmental Coverage

Product

Endoscopes

Balloon Sinus Dilation Devices

Sinus Stents/Implants

Hheld Instruments

Procedure Type

Stalone Sinus Dilation Procedures Hybrid Sinus Dilation Procedures

and End User

Hospitals

ENT Clinics

Ambulatory Surgical Centers

Regional and Country Coverage

North America (US, Canada, Mexico)

Europe (UK, Germany, France, Russia, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, Australia, Rest of APAC)

South / South & Central America (Brazil, Argentina, Rest of South/South & Central America)

Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of MEA)

Market Leaders and Key Company Profiles

Acclarent, Inc.

Aed.MD

DalentMedical

Entellus Medical, Inc.

Innaccel

Intersect ENT, inc.

Medtronic

Olympus Corporation

SinusysCorporation

Smith and Nephew

Other key companies 

What are Perks for Buyers?

The research will guide you in decisions and technology trends to adopt in the projected period.

Take effective Sinus Dilation market growth decisions and stay ahead of competitors

Improve product/services and marketing strategies.

Unlock suitable market entry tactics and ways to sustain in the market

Knowing market players can help you in planning future mergers and acquisitions

Visual representation of data by our team makes it easier to interpret and present the data further to investors, and your other stakeholders.

Do We Offer Customized Insights? Yes, We Do!

The The Insight Partners offer customized insights based on the client’s requirements. The following are some customizations our clients frequently ask for:

The Sinus Dilation market report can be customized based on specific regions/countries as per the intention of the business

The report production was facilitated as per the need and following the expected time frame

Insights and chapters tailored as per your requirements.

Depending on the preferences we may also accommodate changes in the current scope.

Author’s Bio:

Sunil Jadhav

Senior Market Research Expert at The Insight Partners

[jayanthitbrc]

Global Sinus Dilation Devices Market Overview – Market Growth Analysis And Key Drivers

The Sinus Dilation Devices Global Market Report 2023, provides comprehensive information on the sinus dilation devices market across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Sinus Dilation Devices Market’s Growth:

The global sinus dilation devices market is expected to grow from $2.54 billion in 2022 to $2.77 billion in 2023 at a compound annual growth rate (CAGR) of 9.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The sinus dilation devices market is expected to reach $3.79 billion in 2027 at a CAGR of 8.2%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

Technological advancements are a key trend gaining popularity in the sinus dilation device market. Major companies in the sinus dilation devices market are introducing technologically advanced devices to sustain their position in the market. For instance, in July 2021, Intersect ENT, a US-based manufacturer of sinus implants, launched the VenSure balloon sinus dilation system and Cube 4D navigation system to improve workflow. The VenSure balloon sinus dilation system is a balloon dilation system that uses integrated chip-on-the-tip electromagnetic technology. It also has an ergonomic design, which makes it a great fit in hand and allows easy maneuvering and handling.

The sinus dilation devices market is segmented:

1) By Product: Balloon Sinus Dilation Devices, Endoscopes, Functional Endoscopic Sinus Surgery (FESS) Instruments Set, Sinus Stents or Implants, Other Products

2) By Procedure: Standalone, Hybrid

3) By Application: Adult, Pediatric

4) By End User: Hospitals, ENT Clinics, Other End Users

North America was the largest region in the sinus dilation devices market in 2022.

The table of contents in TBRC’s sinus dilation devices market report includes:

1. Executive Summary

2. Market Characteristics

3. Market Trends And Strategies

4. Impact Of COVID-19

5. Market Size And Growth

6. Segmentation

7. Regional And Country Analysis

.

.

.

27. Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions

29. Future Outlook and Potential Analysis

Learn About Us:  The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:  The Business Research Company  Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[meghanester]

Ear and Nasal Packing Market to Grow by a CAGR of ~5% during 2023 – 2035

Research Nester published a report titled “Ear and Nasal Packing Market: Global Demand Analysis & Opportunity Outlook 2035” which delivers detailed overview of the global ear and nasal packing market in terms of market segmentation by type, material, end-user, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global ear and nasal packing market is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2023 – 2035. The market is bifurcated on the basis of material into bio absorbable, and non-absorbable. Out of these, the bio absorbable segment is anticipated to gain a substantial share over the forecast period, owing to the self-dissolving property of bio absorbable packing in the body. As it gets absorbed after a few days of the surgery, it eliminates the need to remove them post-surgery. This is estimated to boost the segment growth.

Get a Sample PDF Brochure: https://www.researchnester.com/sample-request-4035

The global ear and nasal packing market is forecasted to witness growth on the back of increasing number of ear and nose surgeries, along with the rising prevalence of diseases, such as, tonsils, sinusitis, and allergic rhinitis. Moreover, growing demand for minimally invasive surgeries, backed by increasing healthcare expenditure and favorable reimbursement policies, are further estimated to boost the market growth. According to the data by the World Bank, 9.845% of the gross domestic product was spent on healthcare in 2019. 

On the basis of geographical analysis, the global ear and nasal packing market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the North America region is anticipated to garner the largest market share throughout the forecast period on the back of the increasing incidences of ear and nose disorders, such as, sinus, along with the presence of an efficient healthcare system in the region. According to the data by the Center for Disease Control and Prevention, in the U.S., 11.6% adults were diagnosed with sinusitis.

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

Request for customization @ https://www.researchnester.com/customized-reports-4035

Increasing Prevalence of Sinusitis across the Globe to boost the Market Growth

Sinus is a very common condition that can cause extreme pain in the nasal passage, headache, breathing issues, and cough. In fact, In the United States, chronic rhino sinusitis affects 1% to 5% of the population. Surgery or dilation devices are required, in case of acute sinusitis. As a result, the demand for ear and nasal packing is also estimated to surge in the upcoming years. This is estimated to boost the market growth.

However, lack of awareness about ENT health and care is expected to operate as key restraint to the growth of global ear and nasal packing market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global ear and nasal packing market which includes company profiling of Cerecor, Inc., Stryker Corporation, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, AbbVie Inc., Smith & Nephew plc, Amgen Inc., Novartis AG, Bayer AG, and Progenity, Inc. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global ear and nasal packing market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.     

Obtain this Report @ https://www.researchnester.com/reports/ear-and-nasal-packing-market/4035

About Us

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

[mi-researchreports]

Sinus Dilation Devices Market is poised to grow at a CAGR of 8.8% by 2028. Rising Demand for Minimally Invasive Procedures and Increasing Prevalence of Sinusitis foster industry growth.

[rohit0024]

Sinus Dilation Device Market Worth $4.6 Billion By 2028 | CAGR: 11.0%

Sinus Dilation Device Market Growth & Trends The global sinus dilation device market size is estimated to reach USD 4.6 billion by 2028, registering a CAGR of 11.0%, according to a new report by Grand View Research, Inc. Changes in lifestyle, increasing cases of obesity, and a resultant rise in the incidence of sinus-related conditions are the major factors contributing to the market growth. The…